$2.85 Billion is the total value of SAMLYN CAPITAL, LLC's 227 reported holdings in Q3 2010. The portfolio turnover from Q2 2010 to Q3 2010 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2010 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2010-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LPL FINL HLDGS INC | 33 | Q2 2024 | 7.7% |
AMAZON COM INC | 33 | Q2 2024 | 4.1% |
BIOGEN INC | 30 | Q3 2023 | 4.7% |
VOYA FINL INC | 25 | Q4 2023 | 5.8% |
BURLINGTON STORES INC | 25 | Q1 2024 | 3.7% |
WAYFAIR INC | 24 | Q2 2023 | 1.5% |
CONSTELLATION BRANDS INC | 23 | Q4 2018 | 4.6% |
HDFC BANK LTD | 23 | Q3 2020 | 3.5% |
INTRA-CELLULAR THERAPIES INC | 23 | Q3 2022 | 0.8% |
ICICI BK LTD | 22 | Q1 2023 | 4.0% |
View SAMLYN CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Applied Minerals, Inc. | March 11, 2024 | 85,144,328 | 17.6% |
Inozyme Pharma, Inc. | February 14, 2024 | 3,372,558 | 5.5% |
Merus N.V. | February 14, 2024 | 3,412,410 | 5.9% |
Vinci Partners Investments Ltd. | February 14, 2024 | 2,629,571 | 6.5% |
Eliem Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Glass Houses Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
Perella Weinberg PartnersSold out | February 14, 2023 | 0 | 0.0% |
Satsuma Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Falcon Minerals CorpSold out | February 14, 2022 | 0 | 0.0% |
Sculptor Capital Management, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View SAMLYN CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-09-20 |
N-PX | 2024-08-30 |
13F-HR | 2024-08-14 |
SC 13G/A | 2024-08-01 |
13F-HR | 2024-05-15 |
SC 13G/A | 2024-05-13 |
SC 13D/A | 2024-03-11 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View SAMLYN CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.